¥8.19 ($1.22)

+0.30 (+3.80%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 54 · ¥13.2B mcap · 1.29B float · 0.975% daily turnover

Revenue

$3.9B -0.2% ▼

5Y CAGR: +9.7%

Gross Profit

$1.8B +174.8% ▲

5Y CAGR: +7.4%

Operating Income

$994M +437.4% ▲

5Y CAGR: +8.3%

Net Income

$826M +536.1% ▲

5Y CAGR: +6.4%

EPS (Diluted)

$0.50 +516.7% ▲

5Y CAGR: +5.4%

EBITDA

$1.1B +737.0% ▲

5Y CAGR: +9.6%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$2.9B	$3.7B	$3.7B	$3.9B	$3.9B
YoY Growth	+18.0%	+26.5%	+0.7%	+5.9%	-0.2%
Cost of Revenue	$1.2B	$1.6B	$1.8B	$3.3B	$2.1B
Gross Profit	$1.7B	$2.1B	$1.9B	$659M	$1.8B
Gross Margin	57.6%	56.5%	52.1%	16.8%	46.2%
R&D Expenses	$188M	$221M	$264M	$372M	$330M
SG&A Expenses	$550M	$606M	$618M	$566M	$488M
Operating Expenses	$802M	$901M	$761M	$954M	$817M
Operating Income	$877M	$1.2B	$1.2B	-$295M	$994M
Operating Margin	30.1%	32.1%	31.6%	-7.5%	25.3%
Interest Expense	$61M	$94M	$60M	$81M	$78M
Income Before Tax	$915M	$1.2B	$1.2B	-$295M	$992M
Tax Expense	$118M	$140M	$99M	-$105M	$166M
Net Income	$806M	$1.1B	$1.1B	-$189M	$826M
Net Margin	27.7%	28.7%	29.4%	-4.8%	21.1%
EPS (Diluted)	$0.51	$0.67	$0.68	$-0.12	$0.50
EBITDA	$1.0B	$1.3B	$1.2B	-$178M	$1.1B
Shares Outstanding	1.58B	1.58B	1.61B	1.58B	1.65B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$945M	$836M	$885M	$1.1B	$946M	$1.1B	$929M	$998M
Cost of Revenue	$529M	$303M	$581M	$608M	$533M	$673M	$629M	$668M
Gross Profit	$417M	$533M	$305M	$487M	$413M	$392M	$300M	$330M
Gross Margin	44.1%	63.8%	34.4%	44.5%	43.7%	36.8%	32.3%	33.1%
R&D Expenses	$42M	$114M	$69M	$73M	$119M	$83M	$33M	$0
SG&A Expenses	$86M	$173M	$126M	$177M	$148M	$177M	$168M	$80M
Operating Expenses	$167M	$248M	$212M	$268M	$257M	$150M	$203M	$225M
Operating Income	$249M	$285M	$93M	$219M	$156M	$241M	$97M	$105M
Operating Margin	26.4%	34.1%	10.5%	20.0%	16.5%	22.7%	10.4%	10.5%
Interest Expense	$17M	$16M	$14M	$11M	$18M	$12M	$16M	$15M
Income Before Tax	$247M	$285M	$93M	$217M	$152M	$237M	$98M	$92M
Tax Expense	$47M	$65M	$8M	$16M	$9M	$85M	$9M	-$6M
Net Income	$201M	$220M	$85M	$202M	$143M	$152M	$89M	$99M
Net Margin	21.2%	26.4%	9.6%	18.4%	15.1%	14.3%	9.6%	9.9%
EPS (Diluted)	$0.12	$0.13	$0.05	$0.13	$0.09	$0.09	$0.05	$0.06
EBITDA	$320M	$282M	$145M	$279M	$170M	$313M	$114M	$105M
Shares Outstanding	1.62B	1.67B	1.69B	1.58B	1.62B	1.61B	1.78B	1.61B

603707.SS SHH